ZORBAX RRHD 300-HILIC
ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable you to resolve peptide glycoforms.
Receive your quote directly from the manufacturer.
ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable you to resolve peptide glycoforms.
ZORBAX RRHD 300-HILIC columns are part of the AdvanceBio family of columns. AdvanceBio columns are designed to deliver consistent, exceptional performance for the separation and characterization of peptides and proteins, antibodies, conjugates, new biological entities, and biopharmaceuticals. The science behind AdvanceBio columns helps to advance accuracy and productivity so you get more information with every characterization.
Features:
- Alternative selectivity to reversed-phase: HILIC functionality is specifically designed to resolve glycopeptide variants.
- Excellent peak shape for polar glycopeptides: These polar compounds typically cannot be resolved by reversed-phase columns.
- Fast analysis and 1200-bar stability: 1.8 µm particles allow ZORBAX RRHD 300-HILIC columns to be used with UHPLC for faster separations without compromising data accuracy.
